Mer­ck KGaA adds to gene ther­a­py man­u­fac­tur­ing boom with €100M fa­cil­i­ty in Cal­i­for­nia

Add a new, €100 mil­lion Cal­i­for­nia fa­cil­i­ty to the grow­ing gene ther­a­py in­fra­struc­ture.

Mer­ck KGaA an­nounced they are open­ing a sec­ond gene ther­a­py and vi­ral …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER